Nanofat and Microfat Injections: What Emulsified Fat Can and Cannot Do for Skin Quality, Under-Eye Darkness, and Scars, and Why the Word "Stem Cells" Should Make You Slow Down

A patient in their early fifties comes in asking about the dark, slightly crepey skin under their eyes. They have tried a hyaluronic acid filler in the tear trough, which gave them a faint bluish swelling that took a dissolving injection to correct. They have tried a series of chemical peels. A friend has told them about something called nanofat: their own fat, processed into a liquid, injected just under the skin, full of stem cells, "regenerating" the tissue from within. The clinic the friend used describes it as the most natural treatment in aesthetic medicine, because nothing foreign goes into the body.

Some of that description is accurate. Nanofat is the patient's own tissue. It does contain cells other than fat cells, including a population that researchers call the stromal vascular fraction, and some of those cells have properties that resemble stem cells in a laboratory dish. It has been used, in published case series, for under-eye discoloration, fine wrinkles, and scars. What the description leaves out is almost everything that would help the patient decide: that nanofat adds essentially no volume, that the evidence consists mostly of small uncontrolled studies, that "stem cell" is doing a great deal of unearned work in the marketing, that any facial fat injection carries a small risk of serious vascular complications, and that the regulatory status of the procedure depends on exactly how the fat is handled.

Microfat, the other half of this conversation, is less mysterious and in some ways more useful. It is ordinary fat grafting done with smaller instruments and smaller parcels, which allows fat to be placed in thin-skinned areas such as the lower eyelid junction, the lips, and the temples without the lumps that larger grafts can cause there. The two terms are often used interchangeably in advertising. They are not the same thing, and a patient who understands the difference is already in a much better position to evaluate what is being offered.

What nanofat and microfat actually are

The short answer: microfat is intact fat harvested and injected through very fine cannulas so the grafts are small enough to survive and lie smoothly in thin tissue, while nanofat is fat that has been mechanically emulsified and filtered until nearly all the fat cells are destroyed, leaving a liquid that carries no meaningful volume and is used for its effects on skin quality rather than for filling.

Conventional facial fat grafting, described in detail in the piece on fat transfer to the face, harvests fat with a liposuction cannula, purifies it (by settling, centrifugation, or filtration), and injects it in small threads to restore volume in areas such as the cheeks, temples, and jawline. The graft has to acquire a blood supply from the surrounding tissue to survive, which is why it is placed in many small deposits rather than a single mass. The biology of that process, and why a meaningful fraction of transferred fat never survives, is covered in the piece on fat graft survival.

Microfat takes the same principle further. The fat is harvested with a cannula that has very small side holes, so the parcels of tissue drawn out are much smaller than in conventional harvesting. It is then injected through fine cannulas, which allows the surgeon to place it close to the surface in areas where a larger graft would be visible or palpable. Some surgeons go smaller still and describe the result as "millifat" and "microfat" tiers by harvesting cannula size. The terms are not standardized, and a patient should ask what the surgeon means by them rather than assume.

Nanofat is a different product. The technique most often cited was described by Patrick Tonnard and colleagues in a 2013 paper in Plastic and Reconstructive Surgery, the journal of the American Society of Plastic Surgeons. Harvested microfat is pushed back and forth between two syringes connected by a small connector, many times over, until it turns into an emulsion. That emulsion is then passed through a fine filter to remove connective tissue strands. The authors' own analysis found that the mechanical processing destroyed the viable fat cells while leaving a population of other cells from the stromal vascular fraction. The resulting liquid can be injected through a sharp needle into the skin itself or just beneath it.

That is the crucial distinction. Microfat is a filler made of living fat. Nanofat is not a filler at all. It cannot replace lost volume, lift a hollow, or reshape a contour, and a practice that sells it for those purposes is either confusing the terms or counting on the patient to. For true volume replacement, the realistic options remain fat grafting, dermal fat grafts (compared in the piece on dermal fat grafts versus fat transfer), or fillers.

What the evidence actually shows

The short answer: the published evidence for nanofat consists largely of small case series and a limited number of comparative studies, reporting improvements in skin texture, fine wrinkles, under-eye discoloration, and scar appearance, but with inconsistent measurement, short follow-up, few control groups, and frequent combination with other treatments, so the honest summary is "promising and unproven" rather than "regenerative."

The original nanofat report described its use for scars, wrinkles, and under-eye discoloration, with photographs showing improvement in skin quality. Since then, a steady stream of papers has followed, many from the plastic surgery and dermatology literature, reporting improvement in acne scars, burn scars, surgical scars, perioral wrinkles, and dark circles. Systematic reviews of these studies, published in the plastic surgery literature, have repeatedly reached the same verdict: the results are encouraging, patient satisfaction is generally high, and complications are rare, but the studies are small, methodologically heterogeneous, and often lack objective outcome measures or controls.

Three problems recur. The first is combination. Nanofat is frequently injected alongside microneedling, fractional laser treatment, platelet-rich plasma, or conventional fat grafting, which makes it difficult to know which part of the treatment produced the improvement. Microneedling and laser resurfacing improve scars and skin texture on their own, as discussed in the piece on acne scar treatment and the piece on ablative versus non-ablative laser resurfacing. Platelet-rich plasma has its own mixed evidence base, reviewed in the piece on the vampire facial and PRP.

The second is measurement. Many studies rely on before-and-after photographs and patient or surgeon satisfaction scores. Photographs are highly sensitive to lighting, camera distance, makeup, and expression, and under-eye darkness in particular changes dramatically with light angle. The problem is not unique to nanofat; it runs through much of the aesthetic literature, and it is part of why the piece on natural results and plastic surgery marketing urges skepticism about photos without standardized conditions.

The third is duration. Some studies follow patients for months, fewer for more than a year. Skin quality changes slowly and naturally varies with season, sun exposure, and skincare, so short follow-up leaves room for improvements that are real but temporary, or apparent but unrelated to the injection.

None of this means nanofat does nothing. Laboratory studies show that the stromal vascular fraction and the growth factors it releases can influence blood vessel formation and collagen production, and the clinical case series are consistent with a modest effect on skin quality. It means the size, reliability, and duration of that effect are not established, and a patient paying for it should understand they are paying for a plausible treatment with a limited evidence base, not a proven regenerative therapy.

"

Nanofat is the patient's own tissue, and it may genuinely improve skin quality. But "your own cells" is not the same as "proven," and "contains stem cells" is not the same as "regenerates your skin."

"

The stem cell question, and where the regulatory lines sit

The short answer: emulsified fat contains a mixed population of cells, only some of which behave like stem cells in the laboratory, and there is no good evidence that those cells turn into new skin after injection, while the U.S. Food and Drug Administration regulates fat-derived products more strictly once they are manipulated beyond minimal processing or used for purposes other than their natural function.

The stromal vascular fraction is the collection of non-fat cells found in adipose tissue: cells from blood vessel walls, immune cells, fibroblasts, and a subset called adipose-derived stromal or stem cells, which in culture can divide and develop along several cell lines. Much of the regenerative marketing leans on that last group. The reality is more modest. Nanofat contains an unknown and variable number of these cells, determined by the patient, the harvest site, and the processing. Most researchers who study them think their effects, if any, come mainly from the signaling molecules they release, which can influence the surrounding tissue, rather than from the cells becoming new skin. The broader gap between stem cell claims and stem cell evidence in aesthetic practice is covered in the piece on stem cell claims in aesthetic surgery.

The regulatory side matters because it shapes what a practice can legally do. The FDA regulates human cells and tissues through a framework that distinguishes between products that are only minimally manipulated and used for their normal function, and products that are more than minimally manipulated or used for a different function. Autologous fat that is removed and reinjected in the same surgical procedure has traditionally been treated as outside the stricter drug and biologic pathway. The FDA's guidance on minimal manipulation and homologous use, however, makes clear that processing adipose tissue to isolate cells, such as enzymatic digestion to extract the stromal vascular fraction, generally moves the product into the category that requires agency approval. The agency has also issued repeated public warnings about unapproved stem cell treatments and has taken enforcement action against clinics offering them.

Where exactly mechanical emulsification, as in nanofat, falls within that framework is a question the practice should be able to answer clearly, and the patient does not need to become a regulatory lawyer to notice warning signs. A clinic that isolates, concentrates, cultures, or stores cells, that offers to "bank" them for future use, that promotes treatment of diseases or conditions outside aesthetic skin quality, or that describes the procedure as stem cell therapy in its marketing is operating in a very different space from a surgeon who emulsifies a small amount of fat during a facial fat grafting procedure and injects it the same day.

Where microfat earns its place, and where it causes trouble

The short answer: microfat is most useful where skin is thin and conventional grafts would show, such as the junction between the lower eyelid and cheek, the temples, the lips, and the backs of the hands, but those same thin areas are where visible lumps, overcorrection, and irregularities are most likely if the technique or the volume is wrong.

The lower eyelid is the classic example, and the one where the most patients come to grief. A hollow tear trough can be improved with fat, which has the advantage of being soft and not producing the bluish discoloration some hyaluronic acid fillers cause in thin skin. But the lower eyelid skin is among the thinnest on the body, and fat that is placed too superficially, in too large a parcel, or in too great a volume can form visible, firm lumps that persist for years. Unlike hyaluronic acid filler, which can usually be dissolved (as described in the piece on dissolving dermal filler), fat cannot be dissolved. Correcting it means removing it surgically, suctioning it, or attempting steroid injections, each with its own risks. The broader question of what helps under-eye darkness, which is often pigment or shadow rather than volume loss, is covered in the piece on under-eye dark circles, and the problems of an over-operated lower eyelid in the piece on revision blepharoplasty.

Fat also has a behavior that fillers do not: it can grow. Grafted fat retains the characteristics of the donor site, and when a patient gains weight, the grafted fat can enlarge along with the rest of their fat. A modest lower eyelid graft in a thin patient can become a visible puffiness after later weight gain. The reverse also applies. Patients who lose substantial weight, including with GLP-1 medications, may lose some of the grafted volume, a dynamic discussed in the piece on facial volume loss with weight-loss drugs.

Other thin-skinned areas carry similar tradeoffs. Microfat in the lips can add softness and some fullness but is less predictable than filler and harder to adjust; the alternatives are compared in the piece on surgical lip lift versus filler, and fine lines around the mouth are covered in the piece on perioral rejuvenation. Microfat and nanofat in the backs of the hands have been reported in case series, alongside fillers, as outlined in the piece on hand rejuvenation.

Then there is the complication that makes any facial fat injection a serious medical procedure. Fat, like filler, can be injected into a blood vessel. When that happens, it can block the vessel and cause tissue death, and in the rare and catastrophic case, when fat travels into the arteries that supply the eye, it can cause blindness or stroke. Reviews of vascular complications from facial injections have identified autologous fat among the materials most associated with vision loss, and unlike hyaluronic acid, there is no enzyme that dissolves a fat embolus. The general mechanisms and warning signs are discussed in the piece on filler vascular occlusion risk. The techniques that reduce the risk (blunt cannulas for deeper placement, small volumes, slow low-pressure injection, anatomical knowledge of danger zones) are exactly what distinguishes a trained surgeon from an occasional injector.

Nanofat is often injected with a sharp needle into the skin, which raises the obvious question of whether it carries the same risk. The volumes are small, the injection is superficial, and serious complications have rarely been reported, but "rarely reported" in a technique studied mostly in small series is not the same as "impossible." The other common complications of fat grafting, including oil cysts, firm nodules, and calcification, are discussed in the piece on fat necrosis after fat transfer.

Who should be doing it, and how it compares with the alternatives

The short answer: fat harvesting and facial fat injection are surgical procedures that belong with a board-certified plastic or facial plastic surgeon who does them regularly, and for skin quality alone, the alternatives (laser resurfacing, microneedling, biostimulatory fillers, and approved skin boosters) often have stronger evidence and fewer risks.

Every nanofat or microfat treatment begins with liposuction, even if a small one. That means a donor site, local or general anesthesia, sterile technique, and a surgeon who understands both harvesting and injection anatomy. The rise of med spas offering "fat transfer" or "stem cell facials" makes the supervision question central, and it is covered in the piece on who is injecting you in a med spa. The credentials worth checking are explained in the piece on board certifications.

For patients whose goal is skin quality (texture, fine lines, crepiness, mild discoloration), it is worth weighing nanofat against the alternatives. Resurfacing lasers and chemical peels have decades of evidence for texture and fine lines. Biostimulatory fillers such as poly-L-lactic acid produce a gradual collagen response with more controlled studies behind them, as compared in the piece on biostimulatory versus hyaluronic acid fillers and explained in the piece on the Sculptra collagen timeline. Hyaluronic acid "skin boosters" have a specific approved status in the United States, clarified in the piece on which skin boosters are approved. None of these requires a donor site.

Nanofat's strongest case is often as an addition rather than a stand-alone treatment. A patient already having a facelift or facial fat grafting under anesthesia has fat available at essentially no additional surgical cost, and adding a small amount of emulsified fat to scars, fine lines, or the lower eyelid skin during that procedure is a reasonable, low-risk choice for many surgeons. A patient scheduling liposuction solely to obtain nanofat for under-eye darkness, by contrast, is accepting surgical risks for an uncertain benefit and should compare that trade carefully with nonsurgical options.

Scars deserve a separate mention because they are where some of the more interesting data sits. Case series and some comparative studies report improvement in pliability, texture, and appearance of mature scars, including burn and surgical scars, after fat grafting and nanofat. For a patient with a stubborn scar that has not responded to conventional care (silicone, massage, steroid injections, laser, described in the piece on scar care after plastic surgery), it is a reasonable conversation to have with a plastic surgeon, with the understanding that the results are variable.

Finally, the basics of fat survival still apply, and patients can influence them. Nicotine constricts blood vessels and impairs graft survival, which is why the piece on smoking cessation before surgery applies to fat grafting as much as to a facelift. Stable weight before and after treatment makes results more predictable. Realistic expectations about the need for more than one session, particularly for skin quality, avoid disappointment.

The honest summary

Microfat and nanofat are two different techniques that marketing often blurs together. Microfat is living fat harvested and injected in very small parcels so it can restore volume in thin-skinned areas such as the lower eyelid, temples, lips, and hands. Nanofat is fat that has been mechanically emulsified and filtered until almost no fat cells survive, leaving a liquid that adds no real volume and is used for skin quality, discoloration, and scars.

The evidence for nanofat is real but thin: small, often uncontrolled case series, frequent combination with other treatments, reliance on photographs, and short follow-up. It may produce a modest improvement in skin texture and scar appearance. It has not been shown to regenerate skin, and the stem cell language used to sell it outruns the science. Where processing moves toward isolating, concentrating, or storing cells, the FDA's rules become stricter, and the agency has repeatedly warned about unapproved stem cell treatments.

The risks are the risks of fat grafting in the face. Fat cannot be dissolved, so lumps and overcorrection in thin skin can be long-lasting. Grafted fat can change with weight. And any facial fat injection carries a small risk of vascular occlusion, including, in rare cases, blindness, which makes technique and training essential.

For a patient already having facial surgery or fat grafting, adding nanofat is often a sensible extra. For a patient considering liposuction solely to obtain it, the alternatives (lasers, peels, microneedling, biostimulatory fillers, approved skin boosters) deserve a hard look first. And for any patient hearing the words "stem cells" and "regenerative" in a consultation, the right response is not excitement. It is the three questions: which technique, what evidence, and what exactly happens to the cells.